These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Oral bioavailability of slow-release theophylline from unencapsulated beads in preschool children with chronic asthma. Vaughan LM; Milavetz G; Weinberger MM; Smith GD; Harris JB Ther Drug Monit; 1988; 10(4):395-400. PubMed ID: 3059587 [TBL] [Abstract][Full Text] [Related]
3. Effects of time of dose in relation to food on the bioavailability of Theo-Dur Sprinkle at steady state in asthmatic children. Birkett DJ; Lines DR; Kneebone GM; Green B; Hughes HM Clin Pharmacol Ther; 1989 Mar; 45(3):305-11. PubMed ID: 2920505 [TBL] [Abstract][Full Text] [Related]
4. Apparent inconsistent theophylline absorption from sustained release capsules. Uden DL; Schaber DE; Wyatt RA Clin Pediatr (Phila); 1987 Jun; 26(6):285-7. PubMed ID: 3581636 [TBL] [Abstract][Full Text] [Related]
5. Comparison of a new sustained-release theophylline preparation, TheoBeads, with Theo-Dur tablets in children with asthma. Welch MJ; Orgel HA; Meltzer EO; Kemp JP; Gawchik S; Rooklin AR; Tinkelman DG J Asthma; 1988; 25(5):269-74. PubMed ID: 3182591 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system. González MA; Kisicki J; Straughn AB Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257 [TBL] [Abstract][Full Text] [Related]
7. Comparative steady-state bioavailability of sustained-release theophylline preparations: Theo-Dur, Uni-Dur and Xanthium. Rojanasthien N; Kovjiriyapan K; Manorot M; Pothirat C Asian Pac J Allergy Immunol; 2001 Jun; 19(2):69-78. PubMed ID: 11699723 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of serum theophylline concentrations following administration of sustained-release beads in applesauce to asthmatic preschool children. Leeder JS; Robertson C; Correia J; Isles AF; Levison H; Macleod SM Ann Allergy; 1986 Feb; 56(2):133-7. PubMed ID: 3946845 [TBL] [Abstract][Full Text] [Related]
9. Bioavailability of a new sustained-release theophylline capsule in fasted and non-fasted healthy subjects: single and multiple dosing studies. West RJ; Boehm G; Dwyer M; Williams DB; Sansom LN; Penna AC Biopharm Drug Dispos; 1990 Mar; 11(2):165-77. PubMed ID: 2328301 [TBL] [Abstract][Full Text] [Related]
10. Steady-state evaluation of twice-a-day dosing of a new sustained-release theophylline preparation for young children. Welch MJ; Kemp JP; Orgel HA; Meltzer EO J Asthma; 1985; 22(5):249-52. PubMed ID: 4055657 [TBL] [Abstract][Full Text] [Related]
11. Theophylline absorption from two sustained-release products. Implications for therapeutic drug monitoring. Rogers RJ; Wiener MB; Hill MR; Szefler SJ Am Rev Respir Dis; 1987 Nov; 136(5):1168-73. PubMed ID: 3674579 [TBL] [Abstract][Full Text] [Related]
12. Effect of once daily and twice daily sustained release theophylline formulations on daytime variation of bronchial hyperresponsiveness in asthmatic patients. Ferrari M; Olivieri M; Lampronti G; Bonazza L; Biasin C; Nacci P; Talamini G; Lo Cascio V Thorax; 1997 Nov; 52(11):969-74. PubMed ID: 9487345 [TBL] [Abstract][Full Text] [Related]
14. Comparison of a sustained-release preparation (Theo-Dur) with a conventional preparation (Nuelin) in the treatment of chronic asthma. Haahtela T; Vilkka V; Kulstad S Allergy; 1983 Nov; 38(8):589-92. PubMed ID: 6660438 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of passively absorbed saliva for determination of oral slow-release theophylline bioavailability in children. Vaughan LM; Milavetz G; Weinberger MM; Smith GD; Merrick JG Drug Intell Clin Pharm; 1988 Sep; 22(9):684-7. PubMed ID: 3215109 [TBL] [Abstract][Full Text] [Related]
16. Absorption of sustained-release theophylline tablets. Fagerström PO; Heintz L Int J Clin Pharmacol Ther Toxicol; 1983 Jul; 21(7):359-62. PubMed ID: 6885207 [TBL] [Abstract][Full Text] [Related]
17. A single-dose comparison of three slow-release theophylline oral preparations in healthy Thai volunteers. Kanthawatana S; Tontayapiwat A; Tonsuwannont W; Manorot M Asian Pac J Allergy Immunol; 1996 Jun; 14(1):13-8. PubMed ID: 8980795 [TBL] [Abstract][Full Text] [Related]
18. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system. González MA; Straughan AB Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239 [TBL] [Abstract][Full Text] [Related]
19. Sustained-release theophylline. Pharmacokinetic and therapeutic comparison of two preparations. Menendez R; Kelly HW; Howick J; McWilliams BC Am J Dis Child; 1983 May; 137(5):469-73. PubMed ID: 6846276 [TBL] [Abstract][Full Text] [Related]
20. Steady state pharmacokinetics, metabolism and pharmacodynamics of theophylline in children after unequal twice-daily dosing of a new sustained-release formulation. Reinhardt D; Berdel D; Heimann G; Kusenbach G; von Berg A; Johnson E; Steinijans VW; Staudinger H Chronobiol Int; 1987; 4(3):369-80. PubMed ID: 3677217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]